Hyeon-cheol Gwon

Hyeon-cheol Gwon

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 439 publications

Artificial Intelligence-Driven Angiographic Quantification of Fractional Flow Reserve: Proof-of-Concept Validation Study.

Artificial Intelligence-Driven Angiographic Quantification of Fractional Flow Reserve: Proof-of-Concept Validation Study.

Journal: Journal of the American Heart Association

Published: August 20, 2026

Association of Shock-to-Balloon Time With Outcomes in Acute Myocardial Infarction With Cardiogenic Shock Requiring VA-ECMO.

Association of Shock-to-Balloon Time With Outcomes in Acute Myocardial Infarction With Cardiogenic Shock Requiring VA-ECMO.

Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)

Published: August 17, 2026

Geographic Access to Care and Mortality in Cardiogenic Shock: A Nationwide Cohort Analysis.

Geographic Access to Care and Mortality in Cardiogenic Shock: A Nationwide Cohort Analysis.

Journal: Critical care medicine

Published: August 07, 2026

Korean Artificial Intelligence-Based Risk Model for Predicting Mortality After Acute Myocardial Infarction.

Korean Artificial Intelligence-Based Risk Model for Predicting Mortality After Acute Myocardial Infarction.

Journal: Journal of the American Heart Association

Published: July 25, 2026

Preprocedural clinical and angiographic predictors of improved cardiovascular outcomes with final two-stent implantation in coronary bifurcation lesions; the Bifurcation Two-Stent (BTS) score.

Preprocedural clinical and angiographic predictors of improved cardiovascular outcomes with final two-stent implantation in coronary bifurcation lesions; the Bifurcation Two-Stent (BTS) score.

Journal: Cardiovascular revascularization medicine : including molecular interventions

Published: July 10, 2026

Clinical Outcomes of Complete Revascularization in Acute Myocardial Infarction Patients With High Bleeding Risk and Multivessel Disease.

Clinical Outcomes of Complete Revascularization in Acute Myocardial Infarction Patients With High Bleeding Risk and Multivessel Disease.

Journal: Journal of the American Heart Association

Published: July 03, 2026

Microvascular resistance reserve and cardiovascular outcomes: the FLOW-CMD registry.

Microvascular resistance reserve and cardiovascular outcomes: the FLOW-CMD registry.

Journal: European heart journal

Published: June 28, 2026

Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk: A Systematic Review and Meta-Analysis.

Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk: A Systematic Review and Meta-Analysis.

Journal: JAMA cardiology

Published: June 24, 2026

Discontinuation of Beta-Blocker Therapy after Myocardial Infarction.

Discontinuation of Beta-Blocker Therapy after Myocardial Infarction.

Journal: The New England journal of medicine

Published: March 30, 2026

Korean Society of Interventional Cardiology Expert Consensus for the Management of Chronic Coronary Syndrome: Part 2.

Korean Society of Interventional Cardiology Expert Consensus for the Management of Chronic Coronary Syndrome: Part 2.

Journal: Korean circulation journal

Published: March 18, 2026

Korean Society of Interventional Cardiology Expert Consensus for the Management of Chronic Coronary Syndrome: Part 1.

Korean Society of Interventional Cardiology Expert Consensus for the Management of Chronic Coronary Syndrome: Part 1.

Journal: Korean circulation journal

Published: March 17, 2026

Coronary microvascular dysfunction and cardiovascular outcomes (Multicenter FLOW-CMD Registry): a prospective, multicentre cohort study in South Korea.

Coronary microvascular dysfunction and cardiovascular outcomes (Multicenter FLOW-CMD Registry): a prospective, multicentre cohort study in South Korea.

Journal: Lancet (London, England)

Published: February 20, 2026

Showing 1-12 of 439

Last Updated: 09/26/2026